
We narrowed to 186 results for: Gene
-
Antibody#180083-rAbPurposeAnti-Kv2.1 K+ channel (Rat) recombinant mouse monoclonal antibodyDepositorRecommended ApplicationsImmunohistochemistry and Western BlotReactivityHuman, Mouse, and RatSource SpeciesMouseIsotypeIgG2aTrial SizeAvailable to purchaseAvailable sinceMarch 30, 2022AvailabilityIndustry, Academic Institutions, and Nonprofits
-
Antibody#180098-rAbPurposeAnti-Kv1.1 K+ channel (Rat) recombinant mouse monoclonal antibodyDepositorRecommended ApplicationsImmunohistochemistry and Western BlotReactivityHuman, Mouse, Nematode, and RatSource SpeciesMouseIsotypeIgG2aTrial SizeAvailable to purchaseAvailable sinceMarch 30, 2022AvailabilityIndustry, Academic Institutions, and Nonprofits
-
Antibody#191813-rAbPurposeAnti-Kir2.3 K+ channel (Human) recombinant mouse monoclonal antibodyDepositorRecommended ApplicationsImmunocytochemistry and ImmunohistochemistryReactivityHuman and RatSource SpeciesMouseIsotypeIgG2aTrial SizeAvailable to purchaseAvailable sinceMarch 9, 2023AvailabilityIndustry, Academic Institutions, and Nonprofits
-
Antibody#209588-rAbPurposeAnti-Kvbeta1.2/KCNAB1 K+ channel (Human) recombinant mouse monoclonal antibodyDepositorRecommended ApplicationsWestern BlotReactivityHuman, Mouse, and RatSource SpeciesMouseIsotypeIgG2aTrial SizeAvailable to purchaseAvailable sinceOct. 21, 2024AvailabilityIndustry, Academic Institutions, and Nonprofits
-
Antibody#209578-rAbPurposeAnti-TRIP8b (exon 4) (Rat) recombinant mouse monoclonal antibodyDepositorRecommended ApplicationsImmunocytochemistry and Western BlotReactivityHuman, Mouse, and RatSource SpeciesMouseIsotypeIgG2aTrial SizeAvailable to purchaseAvailable sinceJune 12, 2024AvailabilityIndustry, Academic Institutions, and Nonprofits
-
Antibody#180095-rAbPurposeAnti-Pan-Shank (Rat) recombinant mouse monoclonal antibody. Recognizes Shank1, Shank2 and Shank3.DepositorRecommended ApplicationsImmunohistochemistryReactivityHuman, Mouse, and RatSource SpeciesMouseIsotypeIgG2aTrial SizeAvailable to purchaseAvailable sinceOct. 15, 2022AvailabilityIndustry, Academic Institutions, and Nonprofits